Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · IEX Real-Time Price · USD
0.435
-0.026 (-5.72%)
At close: Jul 19, 2024, 4:00 PM
0.461
+0.026 (5.89%)
Pre-market: Jul 22, 2024, 7:00 AM EDT
Ensysce Biosciences Market Cap
Ensysce Biosciences has a market cap or net worth of $3.30 million as of July 22, 2024. Its market cap has increased by 17.84% in one year.
Market Cap
3.30M
Enterprise Value
141.17K
1-Year Change
17.84%
Ranking
Category
Stock Price
$0.44
Market Cap Chart
Since December 1, 2017, Ensysce Biosciences's market cap has decreased from $249.00M to $3.30M, a decrease of -98.67%. That is a compound annual growth rate of -47.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 3.30M | - |
| Dec 29, 2023 | 3.30M | -40.00% |
| Dec 30, 2022 | 5.50M | -95.18% |
| Dec 31, 2021 | 114.00M | 46.34% |
| Dec 31, 2020 | 77.90M | -70.10% |
| Dec 31, 2019 | 260.50M | 6.11% |
| Dec 31, 2018 | 245.50M | -0.89% |
| Dec 29, 2017 | 247.70M | -0.52% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lipella Pharmaceuticals | 3.48M |
| Xylo Technologies | 3.41M |
| Aptevo Therapeutics | 3.39M |
| Qualigen Therapeutics | 3.33M |
| 60 Degrees Pharmaceuticals | 3.31M |
| ZyVersa Therapeutics | 3.26M |
| Avenue Therapeutics | 3.25M |
| Healthcare Triangle | 3.20M |